Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Cheng

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Plos One|September 19, 2024
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart StudyMarilyn L Kwan, Noel Pimentel, Monika Izano, et al.
Research Square|March 30, 2023
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancerEileen Rillamas-Sun, Marilyn L Kwan, California Carlos, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 15, 2019
Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVADSong Li, Jennifer A Beckman, Richard Cheng, et al.
The Journal of Invasive Cardiology|July 12, 2012
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stentsMichael S Lee, Kyung Woo Park, Si-Hyuck Kang, et al.
Breast Cancer Research and Treatment|June 16, 2023
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancerEileen Rillamas-Sun, Marilyn L Kwan, Carlos Iribarren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart StudyHeather Greenlee, Carlos Iribarren, Jamal S Rana, et al.
JACC. Cardiooncology|April 17, 2025
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council PerspectiveVijay U Rao, Anita Deswal, Daniel Lenihan, et al.
Heart Failure Reviews|April 21, 2026
CalShock: beyond the shock team, building on California's cardiogenic shock system of careFletcher M Bell, Jessica N Holtzman, Harshith P Chandrakumar, et al.
Heart (British Cardiac Society)|January 24, 2024
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statementRichard Cheng, Michelle M Kittleson, Ashutosh D Wechalekar, et al.
Journal of Cardiac Failure|October 8, 2023
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus ConferenceMark H Drazner, Amrut V Ambardekar, Kathryn Berlacher, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Plos One|September 19, 2024
Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart StudyMarilyn L Kwan, Noel Pimentel, Monika Izano, et al.
Research Square|March 30, 2023
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancerEileen Rillamas-Sun, Marilyn L Kwan, California Carlos, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 15, 2019
Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVADSong Li, Jennifer A Beckman, Richard Cheng, et al.
The Journal of Invasive Cardiology|July 12, 2012
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stentsMichael S Lee, Kyung Woo Park, Si-Hyuck Kang, et al.
Breast Cancer Research and Treatment|June 16, 2023
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancerEileen Rillamas-Sun, Marilyn L Kwan, Carlos Iribarren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2022
Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart StudyHeather Greenlee, Carlos Iribarren, Jamal S Rana, et al.
JACC. Cardiooncology|April 17, 2025
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council PerspectiveVijay U Rao, Anita Deswal, Daniel Lenihan, et al.
Heart Failure Reviews|April 21, 2026
CalShock: beyond the shock team, building on California's cardiogenic shock system of careFletcher M Bell, Jessica N Holtzman, Harshith P Chandrakumar, et al.
Heart (British Cardiac Society)|January 24, 2024
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statementRichard Cheng, Michelle M Kittleson, Ashutosh D Wechalekar, et al.
Journal of Cardiac Failure|October 8, 2023
The HFSA Advanced Heart Failure and Transplant Cardiology Fellowship Consensus ConferenceMark H Drazner, Amrut V Ambardekar, Kathryn Berlacher, et al.
Pageof 11